Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity?
about
Purification and molecular cloning of prostacyclin-stimulating factor from serum-free conditioned medium of human diploid fibroblast cellsEighth Gaddum Memorial Lecture. University of London Institute of Education, December 1980. Biological importance of prostacyclinProstacyclin concentrations in haemolytic uraemic syndrome after acute shigellosis in childrenManagement of thrombotic thrombocytopenic purpura.Pathogenesis of Shiga toxin-associated hemolytic uremic syndrome.Cyclosporin-associated thrombotic microangiopathy: successful retreatment with cyclosporin.aHUS caused by complement dysregulation: new therapies on the horizon.Therapeutic apheresis in the treatment of hemolytic uremic syndrome in view of pathophysiological aspects.Recent developments in the pathogenesis of hemolytic uremic syndrome.Plasma therapy for severe hemolytic-uremic syndrome in children in Atlantic Canada.Verotoxin and neuraminidase induced platelet aggregating activity in plasma: their possible role in the pathogenesis of the haemolytic uraemic syndromeProstacyclin production following in vitro mixing of normal with hemolytic-uremic-syndrome serumHemolytic-uremic syndrome and acute renal failure in metastatic adenocarcinoma treated with mitomycin: case report and literature review.Haemolytic-uraemic syndrome presenting as an acute abdomen.In vitro prostacyclin production in the hemolytic-uremic syndrome.Potential for plasma exchange in childrenInhibitor of prostacyclin production in sporadic haemolytic uraemic syndrome.Clinical annotation. Thrombotic thrombocytopenic purpura.Abnormalities of factor VIII related protein multimers in the haemolytic uraemic syndrome.Post-partum hemolytic uremic syndrome: treatment with plasma exchange.Plasmapheresis in the haemolytic-uraemic syndrome in childrenHaemolytic uraemic syndrome: therapeutic effect of plasma infusionHaemolytic-uraemic syndrome: an analysis of prognostic features.Combined plasmapheresis and hemodialysis treatment for severe hemolytic-uremic syndrome following Campylobacter colitis.Increased serum levels of transforming growth factor beta-1 in patients affected by thrombotic thrombocytopenic purpura (TTP): its implications on bone marrow haematopoiesis.Nonrecurrent hemolytic uremic syndrome (HUS de novo) as cause of acute renal failure after renal transplant.Reduced prostacyclin activity in systemic lupus erythematosus.Plasmatic regulation of vascular prostacyclin in pregnancyThe influence of irradiation on the biological half-life of prostacyclin in plasma of patients with gastrointestinal cancer.Glomerular thrombi in renal allografts associated with cyclosporin treatmentTechnical considerations for platelet aggregation and related problems.Abnormalities of vascular prostaglandins in Henoch-Schönlein purpura.Plasmapheresis in the haemolytic-uraemic syndrome in children.Prostacyclin deficiency in haemolytic-uraemic syndrome.
P2860
Q24528269-BA45ACAA-68B6-44A3-9E7A-8C6A6CA0C00FQ28277612-73349881-E0E0-4FEE-BE0C-F790031B4AF7Q30495028-7A15E4FF-448A-4CC4-AA51-E75E694DEBF8Q33333063-C20D0B91-DCF2-4C32-AD31-5184DD3D9020Q33338331-0AED73FB-E5A8-4344-8CC5-00CED3E3C945Q33376527-02707A0A-F8AD-4F60-9160-85CB0902E0A5Q33390198-8FB399E7-2EE8-42D4-8788-DC06AA4A8FF5Q33393870-35009316-2E63-4CAE-BB47-175605DE6B6FQ33399908-09CFA88F-CD63-4DD1-B819-187603D83561Q33400903-AA134E91-E1C3-4DD4-8B7E-37CC82B63C54Q33442517-7C4878EF-F0C4-40BA-942A-235D595D77A7Q33445719-05A01680-BA51-49FB-91A8-CAE182D43747Q33447094-4784807E-A1DF-4971-B93B-06E3E8EAE65BQ33451932-8D11BCB8-3A32-4182-A1BD-79A9CB52615CQ33456213-58895B97-49C7-4CD3-AFC5-5A6DA31FCE12Q33476011-44FFCE8D-0EBA-4DFB-9120-C8805A450FABQ33477382-C3D760F7-A815-4DAC-ADA1-191D735AFFD0Q33477476-8477A99C-5DB8-43A6-9DD5-7B4A7FA487C9Q33478418-52F1FBDE-F216-4459-AA3C-0DE2D1FE57CAQ33480270-4B314C23-AC2A-4D7E-8596-87E605B59CAEQ33481563-4FB9E4E5-3EBE-4A30-875F-4BCEFC289FC5Q33481815-17BF3D8C-8869-4075-A4D5-7B21B3053B35Q33481963-EE4B2C17-604A-4746-BC93-F666359DAF87Q33484658-E149CFB5-181F-4491-B594-D2150A675FF7Q33492942-9B16862C-775D-4AC7-8608-A1C6C94C9B6FQ33498940-9205BF26-B9AA-4DC5-B1F2-C4855DADEC4AQ33552720-0684481F-019F-4A56-BC40-DB0D762E7EEDQ34777523-D4418F26-7E3E-4BEC-A332-0F1681B2C54CQ36051134-0E1645FD-0931-4D0E-A9F6-5BF77542258BQ37189549-4177B87D-D211-4F71-BC5A-6B14F97F2FACQ40174830-C0F088A6-9D4E-4118-B170-EF94C495F8E8Q42998234-26239E28-C754-49FB-8236-A6DC03D34637Q55312731-5D5A5235-A362-4381-B546-20E78475E1EAQ55563939-29B443C6-DF28-46EF-9304-BE8D4AEC7DA5
P2860
Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity?
description
1978 nî lūn-bûn
@nan
1978 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1978 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
name
Haemolytic-uraemic syndrome: d ...... ulating prostacyclin activity?
@ast
Haemolytic-uraemic syndrome: d ...... ulating prostacyclin activity?
@en
type
label
Haemolytic-uraemic syndrome: d ...... ulating prostacyclin activity?
@ast
Haemolytic-uraemic syndrome: d ...... ulating prostacyclin activity?
@en
prefLabel
Haemolytic-uraemic syndrome: d ...... ulating prostacyclin activity?
@ast
Haemolytic-uraemic syndrome: d ...... ulating prostacyclin activity?
@en
P2093
P1433
P1476
Haemolytic-uraemic syndrome: d ...... ulating prostacyclin activity?
@en
P2093
P304
P356
10.1016/S0140-6736(78)91573-8
P407
P577
1978-10-01T00:00:00Z